Give us your opinion on our latest poll, and see what your colleagues are saying. You can see the results of our previous surveys here as well.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Survey: Part B Price Negotiation Could have Significant Impact on Providers
Read More
Intercept Withdraws Ocaliva from Market After FDA Raises Safety Concerns
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s
Teva Launches First Generic GLP-1 Drug for Obesity